(Entertainment-NewsWire.com, August 09, 2018 ) Mushroom is the fleshy fungus which is parasitic in nature i.e. they are dependent on other plants for the food source. Mushrooms can be cultivated with low cost and lowland, therefore the majority of manufacturers are turning towards mushroom cultivation. Mushrooms market is likely to experience tremendous growth over the years owing to rise in food and medical industry.
Button Mushrooms market is anticipated to grow at 7.30% CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD 15.57 billion in 2018 and is expected to reach USD 22.15 billion by 2023.
Mushroom contains proteins with low-cholesterol and low-fat content. The market is mainly driven by increasing demand from the food industry. Surging use of mushrooms as ingredients in various food products fuels the market growth. Consumption of organic food is increasing dramatically in almost all developed and developing countries. Growing awareness among consumers regarding health, diet, and nutrition has increased interest in organic food products, including canned organic fruit and vegetables. However, strict regulations for processing of mushrooms led by the FDA due to the presence of various harmful mushroom species may impede the growth of the market.
The global Button Mushrooms market is segmented on the basis of Product. On the basis of Product, it is segmented into Fresh and Processed Mushrooms. Both fresh and processed mushrooms are used in food industry for the production of several food products. The fresh mushroom held the largest share of the market due to the increased production of the food industry in developing countries. Fresh mushroom dominated the global button mushroom market in terms of revenue
Some of the key players dominating the market are Bonduelle Fresh Europe, Costa Pvt Ltd, Drinkwater’s Button Mushrooms Limited, Monaghan Button Mushrooms Ireland, Monterey Button Mushrooms Inc., Lutece Holdings B.V., The Button Mushroom Company., Okechamp S.A. and Shanghai Finc Bio-Tech Inc.
